# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA637884 | A | Half life value of the compound | 1 | ALA1134748 | assay format | Scientific Literature | ||
2. | ALA873705 | F | Effective dose required to block the audiogenic seizures. | Mus musculus | 2 | ALA1134748 | organism-based format | Scientific Literature | |
3. | ALA751685 | B | In vitro displacement of [3H]MK-801 from N-methyl-D-aspartate glutamate receptor | 4 | ALA1134748 | protein complex format | Scientific Literature | ||
4. | ALA752429 | F | Cardiac sodium channel blocking activity by [14C]guanidinium flux assay | 4 | ALA1134748 | assay format | Scientific Literature | ||
5. | ALA752430 | F | Neuronal sodium channel blocking activity by [14C]guanidinium flux assay | 4 | ALA1134748 | assay format | Scientific Literature | ||
6. | ALA884673 | F | Compound was tested in rotarod motor assay and the effective intravenous dose required to fall from the rod was reported. | Rattus norvegicus | 2 | ALA1134748 | organism-based format | Scientific Literature | |
7. | ALA795539 | F | Compound was tested in hypoxia -ischemia reduction model for percent reduction in lesion volume at the dose 10 mg/kg (iv) | Rattus norvegicus | 1 | ALA1134748 | organism-based format | Scientific Literature | |
8. | ALA795540 | F | Compound was tested in hypoxia -ischemia reduction model for percent reduction in lesion volume at the dose 20 mg/kg (iv) | Rattus norvegicus | 1 | ALA1134748 | organism-based format | Scientific Literature | |
9. | ALA792493 | F | Tested in rat middle cerebral artery occlusion model (MACO model) and percent reduction in total lesion volume at the dose of 12 mg/kg (combination ip and iv) | Rattus norvegicus | 1 | ALA1134748 | organism-based format | Scientific Literature | |
10. | ALA880879 | F | Lowest effective intravenous dose required to observe the behavioral effects (excitation) | 2 | ALA1134748 | assay format | Scientific Literature |